0001288123-18-000016.txt : 20180622 0001288123-18-000016.hdr.sgml : 20180622 20180622123649 ACCESSION NUMBER: 0001288123-18-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180620 FILED AS OF DATE: 20180622 DATE AS OF CHANGE: 20180622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Corvese Brian CENTRAL INDEX KEY: 0001393207 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 18913944 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC. STREET 2: 162 FIFTH AVENUE, SUITE 900 CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-06-20 0 0001098972 AGENUS INC AGEN 0001393207 Corvese Brian C/O AGENUS INC. 149 FIFTH AVENUE, SUITE 500 NEW YORK NY 10010 1 0 0 0 Stock Option, right to buy 5.65 2018-06-20 4 A 0 37500 5.65 A 2019-03-02 2028-03-02 Common Stock 37500 37500 D Restricted Stock Unit 2018-06-20 4 A 0 21276 A 2019-04-19 2019-04-19 Common Stock 21276 21276 D Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019. RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019. Christine M. Klaskin, by Power of Attorney 2018-06-22